Selected research
Industry Research
Topical Analgesics Industry Research Report 2026
Market perspective
The global Topical Analgesics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Topical Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Topical Analgesics is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Topical Analgesics is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Topical Analgesics include Sanofi, Johnson & Johnson, Novartis, Mylan, GSK, Topical BioMedics, THE PURE SOURCE, Teikoku Seiyaku and Qizheng, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Topical Analgesics market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Topical Analgesics Market by Company
Sanofi
Johnson & Johnson
Novartis
Mylan
GSK
Topical BioMedics
THE PURE SOURCE
Teikoku Seiyaku
Qizheng
Mercury Healthcare
Lingrui
Huarun 999
Hisamitsu
Endo
Actavis
Topical Analgesics Segment by Type
Pain Relief Patches
Analgesic Creams
Analgesic Sprays
Topical Analgesics Segment by Application
Muscle Pain
Arthritis Pain
Topical Analgesics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Topical Analgesics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Topical Analgesics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Topical Analgesics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Topical Analgesics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Topical Analgesics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Topical Analgesics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Pain Relief Patches
- Analgesic Creams
- Analgesic Sprays
Applications
- Muscle Pain
- Arthritis Pain
Companies covered
- Sanofi
- Johnson & Johnson
- Novartis
- Mylan
- GSK
- Topical BioMedics
- THE PURE SOURCE
- Teikoku Seiyaku
- Qizheng
- Mercury Healthcare
- Lingrui
- Huarun 999
- Hisamitsu
- Endo
- Actavis
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Topical Analgesics Market Size (2021-2032)
- 2.2.2 Global Topical Analgesics Sales (2021-2032)
- 2.2.3 Global Topical Analgesics Market Average Price (2021-2032)
- 2.3 Topical Analgesics by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Pain Relief Patches
- 2.3.3 Analgesic Creams
- 2.3.4 Analgesic Sprays
- 2.4 Topical Analgesics by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Muscle Pain
- 2.4.3 Arthritis Pain
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Topical Analgesics Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Topical Analgesics Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Topical Analgesics Revenue of Manufacturers (2021-2026)
- 3.4 Global Topical Analgesics Average Price by Manufacturers (2021-2026)
- 3.5 Global Topical Analgesics Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Topical Analgesics, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Topical Analgesics, Product Type & Application
- 3.8 Global Manufacturers of Topical Analgesics, Established Date
- 3.9 Global Topical Analgesics Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sanofi
- 4.1.1 Sanofi Company Information
- 4.1.2 Sanofi Business Overview
- 4.1.3 Sanofi Topical Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sanofi Topical Analgesics Product Portfolio
- 4.1.5 Sanofi Recent Developments
- 4.2 Johnson & Johnson
- 4.2.1 Johnson & Johnson Company Information
- 4.2.2 Johnson & Johnson Business Overview
- 4.2.3 Johnson & Johnson Topical Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Johnson & Johnson Topical Analgesics Product Portfolio
- 4.2.5 Johnson & Johnson Recent Developments
- 4.3 Novartis
- 4.3.1 Novartis Company Information
- 4.3.2 Novartis Business Overview
- 4.3.3 Novartis Topical Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Novartis Topical Analgesics Product Portfolio
- 4.3.5 Novartis Recent Developments
- 4.4 Mylan
- 4.4.1 Mylan Company Information
- 4.4.2 Mylan Business Overview
- 4.4.3 Mylan Topical Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Mylan Topical Analgesics Product Portfolio
- 4.4.5 Mylan Recent Developments
- 4.5 GSK
- 4.5.1 GSK Company Information
- 4.5.2 GSK Business Overview
- 4.5.3 GSK Topical Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 GSK Topical Analgesics Product Portfolio
- 4.5.5 GSK Recent Developments
- 4.6 Topical BioMedics
- 4.6.1 Topical BioMedics Company Information
- 4.6.2 Topical BioMedics Business Overview
- 4.6.3 Topical BioMedics Topical Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Topical BioMedics Topical Analgesics Product Portfolio
- 4.6.5 Topical BioMedics Recent Developments
- 4.7 THE PURE SOURCE
- 4.7.1 THE PURE SOURCE Company Information
- 4.7.2 THE PURE SOURCE Business Overview
- 4.7.3 THE PURE SOURCE Topical Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 THE PURE SOURCE Topical Analgesics Product Portfolio
- 4.7.5 THE PURE SOURCE Recent Developments
- 4.8 Teikoku Seiyaku
- 4.8.1 Teikoku Seiyaku Company Information
- 4.8.2 Teikoku Seiyaku Business Overview
- 4.8.3 Teikoku Seiyaku Topical Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Teikoku Seiyaku Topical Analgesics Product Portfolio
- 4.8.5 Teikoku Seiyaku Recent Developments
- 4.9 Qizheng
- 4.9.1 Qizheng Company Information
- 4.9.2 Qizheng Business Overview
- 4.9.3 Qizheng Topical Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Qizheng Topical Analgesics Product Portfolio
- 4.9.5 Qizheng Recent Developments
- 4.10 Mercury Healthcare
- 4.10.1 Mercury Healthcare Company Information
- 4.10.2 Mercury Healthcare Business Overview
- 4.10.3 Mercury Healthcare Topical Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Mercury Healthcare Topical Analgesics Product Portfolio
- 4.10.5 Mercury Healthcare Recent Developments
- 4.11 Lingrui
- 4.11.1 Lingrui Company Information
- 4.11.2 Lingrui Business Overview
- 4.11.3 Lingrui Topical Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Lingrui Topical Analgesics Product Portfolio
- 4.11.5 Lingrui Recent Developments
- 4.12 Huarun 999
- 4.12.1 Huarun 999 Company Information
- 4.12.2 Huarun 999 Business Overview
- 4.12.3 Huarun 999 Topical Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Huarun 999 Topical Analgesics Product Portfolio
- 4.12.5 Huarun 999 Recent Developments
- 4.13 Hisamitsu
- 4.13.1 Hisamitsu Company Information
- 4.13.2 Hisamitsu Business Overview
- 4.13.3 Hisamitsu Topical Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Hisamitsu Topical Analgesics Product Portfolio
- 4.13.5 Hisamitsu Recent Developments
- 4.14 Endo
- 4.14.1 Endo Company Information
- 4.14.2 Endo Business Overview
- 4.14.3 Endo Topical Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Endo Topical Analgesics Product Portfolio
- 4.14.5 Endo Recent Developments
- 4.15 Actavis
- 4.15.1 Actavis Company Information
- 4.15.2 Actavis Business Overview
- 4.15.3 Actavis Topical Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Actavis Topical Analgesics Product Portfolio
- 4.15.5 Actavis Recent Developments
5 Global Topical Analgesics Market Scenario by Region
- 5.1 Global Topical Analgesics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Topical Analgesics Sales by Region: 2021-2032
- 5.2.1 Global Topical Analgesics Sales by Region: 2021-2026
- 5.2.2 Global Topical Analgesics Sales by Region: 2027-2032
- 5.3 Global Topical Analgesics Revenue by Region: 2021-2032
- 5.3.1 Global Topical Analgesics Revenue by Region: 2021-2026
- 5.3.2 Global Topical Analgesics Revenue by Region: 2027-2032
- 5.4 North America Topical Analgesics Market Facts & Figures by Country
- 5.4.1 North America Topical Analgesics Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Topical Analgesics Sales by Country (2021-2032)
- 5.4.3 North America Topical Analgesics Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Topical Analgesics Market Facts & Figures by Country
- 5.5.1 Europe Topical Analgesics Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Topical Analgesics Sales by Country (2021-2032)
- 5.5.3 Europe Topical Analgesics Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Topical Analgesics Market Facts & Figures by Country
- 5.6.1 Asia Pacific Topical Analgesics Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Topical Analgesics Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Topical Analgesics Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Topical Analgesics Market Facts & Figures by Country
- 5.7.1 South America Topical Analgesics Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Topical Analgesics Sales by Country (2021-2032)
- 5.7.3 South America Topical Analgesics Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Topical Analgesics Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Topical Analgesics Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Topical Analgesics Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Topical Analgesics Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Topical Analgesics Sales by Type (2021-2032)
- 6.1.1 Global Topical Analgesics Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Topical Analgesics Sales Market Share by Type (2021-2032)
- 6.2 Global Topical Analgesics Revenue by Type (2021-2032)
- 6.2.1 Global Topical Analgesics Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Topical Analgesics Revenue Market Share by Type (2021-2032)
- 6.3 Global Topical Analgesics Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Topical Analgesics Sales by Application (2021-2032)
- 7.1.1 Global Topical Analgesics Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Topical Analgesics Sales Market Share by Application (2021-2032)
- 7.2 Global Topical Analgesics Revenue by Application (2021-2032)
- 7.2.1 Global Topical Analgesics Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Topical Analgesics Revenue Market Share by Application (2021-2032)
- 7.3 Global Topical Analgesics Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Topical Analgesics Value Chain Analysis
- 8.1.1 Topical Analgesics Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Topical Analgesics Production Mode & Process
- 8.2 Topical Analgesics Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Topical Analgesics Distributors
- 8.2.3 Topical Analgesics Customers
9 Global Topical Analgesics Analyzing Market Dynamics
- 9.1 Topical Analgesics Industry Trends
- 9.2 Topical Analgesics Industry Drivers
- 9.3 Topical Analgesics Industry Opportunities and Challenges
- 9.4 Topical Analgesics Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst